What's new

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 24, Status: Authorised

Feb 12, 2025 - 10:38
 0
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Audi launches new entry-level version of the Q4 e-tron

Next Article

Dubai’s new architectural benchmark – world’s largest 3D printed lounge interior

Related Posts

Herbal medicinal product: Prunus avium peduncle, Prunus avium L.,Prunus cerasus L., D: Draft under discussion

Herbal medicinal product: Prunus avium peduncle, Prunus...

Feb 27, 2025  0

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0